{"id":"W4385644723","doi":"10.1097/01.hs9.0000967696.13096.54","title":"S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Discontinuation; Internal medicine; Refractory (planetary science); Adverse effect; Gastroenterology; Multiple myeloma; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001229397,0.000361464,0.0004439195,0.0001480263,0.0002727044,0.0001003991,0.0001059042,0.0002138954,0.000298804],"category_scores_gemma":[0.0001574018,0.0002887423,0.0001159967,0.0004003114,0.00009719472,0.0003210518,0.00005291286,0.0002144459,0.0001698088],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009150258,"about_ca_system_score_gemma":0.0001943432,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001801539,"about_ca_topic_score_gemma":0.0003896834,"domain_scores_codex":[0.9976246,0.00006556839,0.0003899776,0.0007259314,0.000626448,0.000567454],"domain_scores_gemma":[0.9984278,0.0002914088,0.0001697984,0.0004949869,0.000266274,0.0003497025],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03383932,0.003684186,0.7938976,0.001131911,0.0007827071,0.0008333362,0.001209683,0.000004657459,0.05526668,0.00009625209,0.0229723,0.08628137],"study_design_scores_gemma":[0.02859642,0.003668661,0.9494376,0.0002289034,0.0001412344,0.00001063043,0.0005482322,0.001838487,0.006166654,0.0001151666,0.008861979,0.0003860859],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946799,0.0006296995,0.0003873695,0.0003108537,0.0002405583,0.002401717,0.000516365,0.0002248069,0.0006087891],"genre_scores_gemma":[0.98351,0.0003646613,0.004667964,0.00004452811,0.0001581373,0.00020993,0.007222604,0.00008795255,0.003734201],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.15554,"threshold_uncertainty_score":0.9999565,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01863870885240338,"score_gpt":0.2789849677210768,"score_spread":0.2603462588686734,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}